India

Now, Oxford-AstraZeneca Vaccine Linked To Rare Neurological Disorder

New Delhi: A rare neurological disorder called Guillain-Barre syndrome have been found in 11 individuals who had received the AstraZeneca-Oxford COVID-19 vaccine.

According to the two studies by clinicians in India and England, published in the Annals of Neurology, this unusual variant of the syndrome is characterised by prominent facial weakness.

Seven such cases have been reported from a regional medical centre in Kerala, India, within two weeks of them being administrated the first dose of this vaccine, which is being produced and distributed in India as Covishield by Serum Institute of India (SII).

“Six out of the seven patients progressed to areflexic quadriplegia and required mechanical ventilatory support,” Boby Varkey Maramattom, from the Department of Neurology, Aster Medcity, Kochi, was quoted as saying by IANS.

“The frequency of GBS was 1.4 to 10 fold higher than that expected in this period for a population of this magnitude. In addition, the frequency of bilateral facial weakness, which typically occurs in less than 20 per cent of GBS cases, suggests a pattern associated with the vaccination,” he added.

Similarly, four cases were reported from Nottingham, England, within three weeks of vaccination.

The British drugmaker’s COVID-19 vaccine was earlier hit by the ban on its use in some European nations after reports that some people who got a dose developed blood clots.

According to an analysis of postvaccination events in Scotland, this vaccine slightly increases the risk of blood clotting and low platelets.

The UK’s Medicine and Healthcare products and Regulatory Agency have so far reported 379 cases of low platelet and blood clotting events, Medical News Today report said.

In February, the UK’s medicines regulator, however, has described the first safety data related to COVID-19 vaccines as “reassuring,” with most side effects reported being mild and in line with those seen with other types of vaccine.

In April, EMA’s safety committee (PRAC) had concluded that unusual blood clots with low blood platelets should be listed as very rare side effects of the vaccine.

OB Bureau

Recent Posts

Burglars Loot Temple Donation Box In Odisha

Berhampur: Continuing to target places of worship in different parts of Odisha, burglars struck at…

18 minutes ago

Indian American Entrepreneur Sriram Krishnan To Lead Trump’s AI Policy

New York: US President-elect Donald Trump has nominated an Indian American entrepreneur and former aide…

22 minutes ago

Parliament Scuffle: BJP MPs Pratap Sarangi & Mukesh Rajput Discharged From Hospital

New Delhi: BJP MPs Pratap Sarangi and Mukesh Rajput, who suffered head injuries in the…

25 minutes ago

3 People Including 2 Toddlers Killed After Truck Runs Over Labourers Sleeping On Pune Footpath

Pune: Three people, including two toddlers, died on Monday when a dumper truck run over…

40 minutes ago

3 Khalistani Terrorists Involved In Attack On Punjab’s Police Station Killed In Encounter In Uttar Pradesh

Lucknow: Three terrorists accused of lobbing a grenade at a police post in Punjab’s Gurdaspur…

59 minutes ago

Odisha: Malkangiri-Visakhapatnam Air Connectivity May Become A Reality In 2025

Malkangiri: If things go as per plan, flight services between Odisha’s Malkangiri town and Visakhapatnam…

1 hour ago

This website uses cookies.